Clinical Trial Update: Metformin for Weight Loss in Schizophrenia [NA]

View source ↗

Summary

A study evaluating metformin for weight loss in people with schizophrenia and obesity was terminated. Results were posted on 2017-02-07.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Schizophrenia

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Schizophrenia, Obesity | NA | Status: TERMINATED | Results posted: 2017-02-07